| scholarly article | Q13442814 |
| P50 | author | Marco Francone | Q42390640 |
| P2093 | author name string | Marco Francone | |
| P2860 | cites work | Titin mutations as the molecular basis for dilated cardiomyopathy | Q24292301 |
| Cardiomyocyte hypertrophy, oncosis, and autophagic vacuolization predict mortality in idiopathic dilated cardiomyopathy with advanced heart failure | Q83756909 | ||
| Familial inflammatory dilated cardiomyopathy | Q83816092 | ||
| Genetics of dilated cardiomyopathy | Q83937340 | ||
| Correlation between left ventricular diastolic function and ejection fraction in dilated cardiomyopathy using magnetic resonance imaging with late gadolinium enhancement | Q84513456 | ||
| Right atrial free-floating thrombus in dilated cardiomyopathy | Q84782695 | ||
| Cardiac MRI: estimation of changes in normalized myocardial gadolinium accumulation over time after contrast injection in patients with acute myocarditis and healthy volunteers | Q84815294 | ||
| Alcohol and drugs: twins or evil in a young heart | Q85011554 | ||
| Right ventricular ischemic injury in patients with acute ST-segment elevation myocardial infarction: characterization with cardiovascular magnetic resonance | Q85056809 | ||
| Comparison of (99m)Tc-MIBI SPECT/18F-FDG PET imaging and cardiac magnetic resonance imaging in patients with idiopathic dilated cardiomyopathy: assessment of cardiac function and myocardial injury | Q85448220 | ||
| Predicting prognosis in dilated cardiomyopathy | Q85652799 | ||
| Peripartum cardiomyopathy: a review | Q85856838 | ||
| [Magnetic resonance imaging of dilated cardiomyopathy] | Q85932816 | ||
| Myocardial oedema as the sole marker of acute injury in Takotsubo cardiomyopathy: a cardiovascular magnetic resonance (CMR) study | Q86866733 | ||
| Fibrosis and mortality in patients with dilated cardiomyopathy | Q87002415 | ||
| Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy | Q87393720 | ||
| Dilated cardiomyopathy | Q87396216 | ||
| Imaging in the management of ischemic cardiomyopathy: special focus on magnetic resonance | Q26824350 | ||
| Acute viral myocarditis | Q27486698 | ||
| Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction | Q28208692 | ||
| Left ventricular remodeling or restoration for congestive heart failure | Q28300601 | ||
| Epidemiology-etiology of dilated cardiomyopathy | Q30320994 | ||
| Prognostic value of stress cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease: a systematic review and meta-analysis | Q30411158 | ||
| Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations | Q30439966 | ||
| Cardiac magnetic resonance imaging in ischemic heart disease: a clinical review. | Q30468452 | ||
| MRI and CT in the diagnosis of coronary artery disease: indications and applications | Q30470368 | ||
| Imaging phenotype vs genotype in nonhypertrophic heritable cardiomyopathies: dilated cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy | Q30473247 | ||
| Does myocardial fibrosis hinder contractile function and perfusion in idiopathic dilated cardiomyopathy? PET and MR imaging study. | Q31049621 | ||
| Regional heterogeneity of resting perfusion in hypertrophic cardiomyopathy is related to delayed contrast enhancement but not to systolic function: a PET and MRI study | Q31058374 | ||
| T2-weighted cardiovascular magnetic resonance imaging | Q31122962 | ||
| Dilated cardiomyopathy | Q33158421 | ||
| Risk stratification in nonischemic dilated cardiomyopathy: Current perspectives. | Q33158844 | ||
| Utility of T2-weighted short-tau inversion recovery (STIR) sequences in cardiac MRI: an overview of clinical applications in ischaemic and non-ischaemic heart disease | Q33712217 | ||
| Breathhold cardiac MRI and MRA. | Q33715604 | ||
| Contrast-enhanced coronary MRA. | Q33766795 | ||
| Coronary MRA--a clinical experience in Europe | Q33766809 | ||
| Myocardial fibrosis detected by cardiac magnetic resonance imaging in heart failure: impact on remodeling, diastolic function and BNP levels | Q33789724 | ||
| Shorter difference between myocardium and blood optimal inversion time suggests diffuse fibrosis in dilated cardiomyopathy | Q33822332 | ||
| Assessment of myocardium at risk with contrast enhanced steady-state free precession cine cardiovascular magnetic resonance compared to single-photon emission computed tomography | Q33912094 | ||
| Myocarditis and long-term survival in peripartum cardiomyopathy. | Q33923402 | ||
| Cardiomyopathy. Diagnosis and management of dilated cardiomyopathy | Q33947702 | ||
| Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy | Q33948128 | ||
| ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriate | Q33999842 | ||
| Sex and gender differences in myocarditis and dilated cardiomyopathy | Q34060039 | ||
| Alcoholic and cocaine-associated cardiomyopathies | Q34095333 | ||
| Alcoholic cardiomyopathy: incidence, clinical characteristics, and pathophysiology | Q34128064 | ||
| Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy | Q34147980 | ||
| Magnetic resonance spectroscopy in human cardiomyopathies | Q34361693 | ||
| The effect of cardiac resynchronization on morbidity and mortality in heart failure | Q34400885 | ||
| The natural history and spectrum of idiopathic dilated cardiomyopathy, including HIV and peripartum cardiomyopathy. | Q40445478 | ||
| Cardiac and skeletal muscle involvement in myotonic dystrophy type 2 (DM2): a quantitative 31P-MRS and MRI study. | Q40479410 | ||
| Pathophysiology of heart failure: changing perceptions | Q41007379 | ||
| Steadily straining toward clinical utility: real-time quantitative CMR of myocardial deformation during stress | Q42872747 | ||
| Contrast-enhanced myocardial inversion time at the null point for detection of left ventricular myocardial fibrosis in patients with dilated and hypertrophic cardiomyopathy: a pilot study | Q43121744 | ||
| Dobutamine stress cardiovascular magnetic resonance imaging in patients after invasive coronary revascularization with stent placement | Q43239603 | ||
| Adenosine-induced stress myocardial perfusion imaging using dual-source cardiac computed tomography | Q43278443 | ||
| EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase | Q43291552 | ||
| Imaging longitudinal cardiac strain on short-axis images using strain-encoded MRI. | Q43690925 | ||
| Prodromal angina is associated with myocardial salvage in acute ST-segment elevation myocardial infarction. | Q43737413 | ||
| Cardiovascular complications of cocaine use. | Q43856570 | ||
| Clinical indications for the use of cardiac MRI. By the SIRM Study Group on Cardiac Imaging | Q43934270 | ||
| Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy | Q44151643 | ||
| Safety and feasibility of high-dose dobutamine-atropine stress cardiovascular magnetic resonance for diagnosis of myocardial ischaemia: experience in 1000 consecutive cases | Q44972590 | ||
| A bi-center cardiovascular magnetic resonance prognosis study focusing on dobutamine wall motion and late gadolinium enhancement in 3,138 consecutive patients | Q44990131 | ||
| Myocardial first-pass perfusion magnetic resonance imaging: a multicenter dose-ranging study | Q45004047 | ||
| Fibrosis and mortality in patients with dilated cardiomyopathy | Q45153470 | ||
| Characteristics of wave fronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: role of increased fibrosis in the generation of reentry | Q45307190 | ||
| Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy | Q45341679 | ||
| Role of cardiovascular magnetic resonance as a gatekeeper to invasive coronary angiography in patients presenting with heart failure of unknown etiology. | Q45341746 | ||
| Changes in right ventricular function measured by cardiac magnetic resonance imaging in patients receiving pulmonary arterial hypertension-targeted therapy: the EURO-MR study | Q45386848 | ||
| Cardiac magnetic resonance imaging in peripartum cardiomyopathy. | Q45904579 | ||
| Measurement of right ventricular mass in normal and dilated cardiomyopathic ventricles using cine magnetic resonance imaging. | Q46036762 | ||
| Assessment of systolic dyssynchrony for cardiac resynchronization therapy is not clinically useful | Q46111822 | ||
| Quantification of atherosclerotic coronary plaque: the missing link between elevated biochemical markers and adverse outcomes in the "vulnerable" patient? | Q46144889 | ||
| Effects of exercise training on myocardial energy metabolism and ventricular function assessed by quantitative phosphorus-31 magnetic resonance spectroscopy and magnetic resonance imaging in dilated cardiomyopathy | Q46604844 | ||
| Severe dilated cardiomyopathy as a consequence of Ecstasy intake | Q46652269 | ||
| Prognostic and therapeutic implications of dipyridamole stress cardiovascular magnetic resonance on the basis of the ischaemic cascade | Q46670195 | ||
| Feasibility of rapid-sequence 31P magnetic resonance spectroscopy in cardiac patients | Q46680161 | ||
| Early diagnosis of hemochromatosis-related cardiomyopathy with magnetic resonance imaging | Q46682253 | ||
| Normal left ventricular dimensions and function: interstudy reproducibility of measurements with cine MR imaging | Q46806117 | ||
| Application of cine nuclear magnetic resonance imaging for sequential evaluation of response to angiotensin-converting enzyme inhibitor therapy in dilated cardiomyopathy | Q46991057 | ||
| Value of contrast-enhanced, balanced cine-MR sequences in the assessment of apparent infarct size after acute myocardial infarction: a prospective comparison with delayed-enhancement sequences | Q47362489 | ||
| ACUT2E TSE-SSFP: a hybrid method for T2-weighted imaging of edema in the heart | Q47954731 | ||
| Novel predictors of left ventricular reverse remodeling in individuals with recent-onset dilated cardiomyopathy | Q48226391 | ||
| Relationship between biological variation in B-type natriuretic peptide and plasma renin concentration in stable outpatients with dilated cardiomyopathy | Q49137220 | ||
| A new approach towards improved visualization of myocardial edema using T2-weighted imaging: a cardiovascular magnetic resonance (CMR) study. | Q50516026 | ||
| [Cardiomyopathy in Italy today: extent of the problem] | Q50558211 | ||
| Incidence, causes, and outcomes of dilated cardiomyopathy in children. | Q50791017 | ||
| Relation between gender, etiology and survival in patients with symptomatic heart failure. | Q50985635 | ||
| Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. | Q51102867 | ||
| Myocardial Scar Visualized by Cardiovascular Magnetic Resonance Imaging Predicts Major Adverse Events in Patients With Hypertrophic Cardiomyopathy | Q51149024 | ||
| Differential diagnosis of suspected apical ballooning syndrome using contrast-enhanced magnetic resonance imaging. | Q51681579 | ||
| Localized spectroscopy from anatomically matched compartments: improved sensitivity and localization for cardiac 31P MRS in humans. | Q52235061 | ||
| Metavinculin mutations alter actin interaction in dilated cardiomyopathy. | Q52545136 | ||
| Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging. | Q52934450 | ||
| Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. | Q52938201 | ||
| Measurement of left ventricular dimensions and function in patients with dilated cardiomyopathy. | Q52965942 | ||
| Magnetic resonance imaging in patients with cardiomyopathies: when and why. | Q52970230 | ||
| Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography. | Q53090784 | ||
| A pattern-based approach to assessment of delayed enhancement in nonischemic cardiomyopathy at MR imaging. | Q53372187 | ||
| Delayed gadolinium-enhanced cardiac magnetic resonance in patients with chronic myocarditis presenting with heart failure or recurrent arrhythmias. | Q53541762 | ||
| Role of cardiac magnetic resonance imaging in identification of amyloid cardiomyopathy. | Q53592474 | ||
| Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. | Q53659656 | ||
| Visualization of ventricular thrombi with contrast-enhanced magnetic resonance imaging in patients with ischemic heart disease. | Q53665218 | ||
| Idiopathic Dilated Cardiomyopathy | Q56987016 | ||
| Myocardial Tissue Characterization Using Magnetic Resonance Noncontrast T1 Mapping in Hypertrophic and Dilated Cardiomyopathy | Q57279198 | ||
| Effect of Posterolateral Scar Tissue on Clinical and Echocardiographic Improvement After Cardiac Resynchronization Therapy | Q57298888 | ||
| Creatine Depletion and Altered Fatty Acid Metabolism in Diseased Human Hearts: Clinical Investigation Using 1H Magnetic Resonance Spectroscopy and 123I BMIPP Myocardial Scintigraphy | Q58275115 | ||
| Noninvasive Diagnosis of Ischemia-Induced Wall Motion Abnormalities With the Use of High-Dose Dobutamine Stress MRI | Q61458742 | ||
| Relationship between right ventricular volumes measured by cardiac magnetic resonance imaging and prognosis in patients with chronic heart failure | Q61716588 | ||
| Impact of pregnancy-related heart failure on humoral immunity: clinical relevance of G3-subclass immunoglobulins in peripartum cardiomyopathy | Q62487877 | ||
| 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure | Q67593279 | ||
| Mechanisms and models in heart failure: the biomechanical model and beyond | Q34422770 | ||
| Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? | Q34510314 | ||
| β1-Adrenoceptor autoantibodies from DCM patients enhance the proliferation of T lymphocytes through the β1-AR/cAMP/PKA and p38 MAPK pathways | Q34541400 | ||
| MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial | Q34738853 | ||
| Prognostic value of late gadolinium enhancement in dilated cardiomyopathy patients. A meta-analysis | Q34824630 | ||
| Virchow and his triad: a question of attribution | Q34824846 | ||
| Cardiomyopathy, familial dilated | Q35015924 | ||
| Late gadolinium enhanced cardiovascular magnetic resonance of lamin A/C gene mutation related dilated cardiomyopathy | Q35102865 | ||
| Coronary magnetic resonance angiography: technical developments and clinical applications | Q35135256 | ||
| Myocarditis and dilated cardiomyopathy An inflammatory link | Q35548716 | ||
| Progressive induction of left ventricular pressure overload in a large animal model elicits myocardial remodeling and a unique matrix signature | Q35621698 | ||
| Incidence of and risk factors for sudden cardiac death in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry | Q35760873 | ||
| Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management | Q35822612 | ||
| Assessment of coronary arteries with total study time of less than 30 minutes by using whole-heart coronary MR angiography. | Q36242743 | ||
| Clinical characteristics and risk factors for peripartum cardiomyopathy | Q36292318 | ||
| Magnetic resonance imaging assessment of ventricular dyssynchrony: current and emerging concepts | Q36344661 | ||
| Cardiac stress MR imaging with dobutamine | Q36484578 | ||
| Genetic mutations and mechanisms in dilated cardiomyopathy | Q36497170 | ||
| Dilated cardiomyopathy: a tale of cytoskeletal proteins and beyond | Q36501691 | ||
| The role of intravenous immunoglobulin in the treatment of chronic heart failure | Q36558817 | ||
| Cardiomyopathies in children | Q36660321 | ||
| MR spectroscopy of the heart | Q36685142 | ||
| Prevalence of overt dilated cardiomyopathy in two regions of England | Q36759217 | ||
| Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy | Q36761955 | ||
| Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy | Q36893306 | ||
| Autoimmune myocarditis, valvulitis, and cardiomyopathy | Q36903541 | ||
| Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis | Q36954858 | ||
| Advances in coronary MRA from vessel wall to whole heart imaging | Q37014066 | ||
| Stress cardiac magnetic resonance imaging with observation unit care reduces cost for patients with emergent chest pain: a randomized trial | Q37027464 | ||
| Modified look-locker inversion recovery T1 mapping indices: assessment of accuracy and reproducibility between magnetic resonance scanners | Q37070852 | ||
| The role of cardiovascular magnetic resonance in the diagnosis and management of cardiomyopathies. | Q37135230 | ||
| Magnetic resonance imaging of cardiovascular fibrosis and inflammation: from clinical practice to animal studies and back | Q37154775 | ||
| Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis). | Q37254072 | ||
| Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling | Q37263689 | ||
| Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy. | Q37305355 | ||
| Visualization of coronary venous anatomy by cardiovascular magnetic resonance | Q37316411 | ||
| Autoimmune mechanisms underlying dilated cardiomyopathy. | Q37402241 | ||
| Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo | Q37435370 | ||
| CT and MR imaging findings in patients with acquired heart disease at risk for sudden cardiac death | Q37485594 | ||
| Genetic polymorphisms in dilated cardiomyopathy | Q37663463 | ||
| The genetics of dilated cardiomyopathy | Q37698904 | ||
| Familial dilated cardiomyopathy secondary to dystrophin splice site mutation | Q37703755 | ||
| Cardiac magnetic resonance imaging: current status and future directions | Q37776517 | ||
| Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases | Q37786123 | ||
| Dilated Cardiomyopathy and Heart Failure in Children | Q37792392 | ||
| The role of cardiac magnetic resonance imaging in the assessment of non-ischemic cardiomyopathy | Q37822294 | ||
| MRI in the assessment of non ischemic myocardial diseases | Q37851708 | ||
| Familial predisposition and microbial etiology in dilated cardiomyopathy | Q37855167 | ||
| Left ventricular wall stress compendium. | Q37872676 | ||
| Contribution of genetic factors to the pathogenesis of dilated cardiomyopathy: the cause of dilated cardiomyopathy: genetic or acquired? (genetic-side). | Q37880549 | ||
| Review and metaanalysis of the frequency of familial dilated cardiomyopathy. | Q37907528 | ||
| Guidelines for the diagnosis and management of familial dilated cardiomyopathy | Q37925295 | ||
| Alcoholic cardiomyopathy: a review | Q37941148 | ||
| Delayed contrast enhancement on MR images of myocardium: past, present, future | Q37947536 | ||
| Cardiomyopathies: focus on cardiovascular magnetic resonance. | Q38020821 | ||
| Pregnancy with dilated and peripartum cardiomyopathy: maternal and fetal outcome. | Q38041416 | ||
| Quantitative assessment of mitral regurgitation: how best to do it. | Q38060007 | ||
| Dilated cardiomyopathy: a disease of the myocardium | Q38072803 | ||
| Diffuse diseases of the myocardium: MRI-pathologic review of cardiomyopathies with dilatation | Q38084282 | ||
| Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance | Q38520098 | ||
| Cardiovascular magnetic resonance imaging-derived mitral valve geometry in determining mitral regurgitation severity | Q39422412 | ||
| Noninvasive detection of coronary artery stenoses with multislice computed tomography or magnetic resonance imaging | Q40287280 | ||
| The emerging role of magnetic resonance imaging and multidetector computed tomography in the diagnosis of dilated cardiomyopathy | Q40438903 | ||
| Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy | Q68189721 | ||
| [Three-dimensional analysis of the regional contractility of the normal and the cardiomyopathic left ventricle using cine-magnetic resonance imaging] | Q68571721 | ||
| Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984 | Q69695239 | ||
| [Imaging of atherosclerosis: magnetic resonance] | Q72034726 | ||
| The cellular basis of dilated cardiomyopathy in humans | Q72262203 | ||
| Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography | Q73092424 | ||
| [Influence of image quality on the diagnostic accuracy of dobutamine stress magnetic resonance imaging in comparison with dobutamine stress echocardiography for the noninvasive detection of myocardial ischemia] | Q73093601 | ||
| Epidemiology of dilated cardiomyopathy: a still undetermined entity | Q73108319 | ||
| Epidemiology of dilated cardiomyopathy. A prospective post-mortem study of 5252 necropsies. The Heart Muscle Disease Study Group | Q73108373 | ||
| Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy | Q73665478 | ||
| Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy | Q73746098 | ||
| Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy | Q73804332 | ||
| In vivo magnetic resonance imaging and surgical histopathology of intracardiac masses: distinct features of subacute thrombi | Q73954206 | ||
| The next horizon in CMR: spectroscopy | Q74495801 | ||
| Cardiac 1H-MR spectroscopy | Q77516208 | ||
| Ventricular remodeling. Mechanisms and prevention | Q77802811 | ||
| Detection and characterization of intracardiac thrombi on MR imaging | Q78532327 | ||
| Three‐dimensional navigator coronary MRA with the aid of a blood pool agent in pigs: Improved image quality with inclusion of the contrast agent first‐pass | Q79080800 | ||
| Gadolinium Cardiovascular Magnetic Resonance Predicts Reversible Myocardial Dysfunction and Remodeling in Patients With Heart Failure Undergoing β-Blocker Therapy | Q79161380 | ||
| CCS/CAR/CANM/CNCS/CanSCMR joint position statement on advanced noninvasive cardiac imaging using positron emission tomography, magnetic resonance imaging and multidetector computed tomographic angiography in the diagnosis and evaluation of ischemic | Q79801309 | ||
| Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological valida | Q79849779 | ||
| Coronary magnetic resonance angiography | Q80566009 | ||
| Giant cell myocarditis triggered by a parvovirus B19 infection | Q80720850 | ||
| [Indications for MRI in coronary disease] | Q80761699 | ||
| [MR imaging and MR spectroscopy for characterization of cardiomyopathies in adolescents - preliminary results] | Q80809455 | ||
| [Use of bivariate survival curves for analyzing mortality of heart failure and sudden death in dilated cardiomiopathy] | Q81121652 | ||
| Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report | Q81262531 | ||
| Identification of diabetic cardiomyopathy with cardiac magnetic resonance imaging | Q82066871 | ||
| Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping | Q82598708 | ||
| Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging | Q82970700 | ||
| Parvovirus b19-induced myocarditis mimicking acute myocardial infarction: clarification of diagnosis by cardiac magnetic resonance imaging | Q83001937 | ||
| [Progress of genetics in familial dilated cardiomyopathy] | Q83151316 | ||
| Delayed enhancement cardiovascular magnetic resonance as a novel technique to predict cardiac events in dilated cardiomyopathy patients | Q83277079 | ||
| Assessment of systolic dyssynchrony for cardiac resynchronization therapy is clinically useful | Q83411372 | ||
| Evaluation of left and right ventricular ejection fraction and volumes from gated blood-pool SPECT in patients with dilated cardiomyopathy: comparison with cardiac MRI | Q83579242 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | dilated cardiomyopathy | Q283656 |
| P304 | page(s) | 365404 | |
| P577 | publication date | 2014-02-04 | |
| P1433 | published in | ISRN radiology | Q27725035 |
| P1476 | title | Role of cardiac magnetic resonance in the evaluation of dilated cardiomyopathy: diagnostic contribution and prognostic significance | |
| P478 | volume | 2014 |
| Q50540854 | Automatic segmentation of right ventricle in cardiac cine MR images using a saliency analysis. |
| Q89522976 | Cardiac Imaging in the Athlete: Shrinking the "Gray Zone" |
| Q30355877 | Dilated Cardiomyopathy: Phosphorus 31 MR Spectroscopy at 7 T. |
| Q90032553 | Emerging role of microRNAs in dilated cardiomyopathy: evidence regarding etiology |
| Q64981978 | Expression of ADAMTS-1 mRNA in myocardium of viral heart disease mice and its clinical significance. |
| Q55397299 | Fatty Images of the Heart: Spectrum of Normal and Pathological Findings by Computed Tomography and Cardiac Magnetic Resonance Imaging. |
| Q64949711 | Galectin-3 as a Predictor of Left Ventricular Reverse Remodeling in Recent-Onset Dilated Cardiomyopathy. |
| Q92974167 | Guideline for Cardiovascular Magnetic Resonance Imaging from the Korean Society of Cardiovascular Imaging-Part 1: Standardized Protocol |
| Q26744429 | Role of cardiac MRI in nonischemic cardiomyopathies |
| Q97645762 | Should CMR be the default imaging modality in clinical trials for heart failure? |
| Q97645758 | Should everyone have an MRI in heart failure? |
| Q48271337 | The evaluation of non-ischemic dilated cardiomyopathy with T1 mapping and ECV methods using 3T cardiac MRI. |
| Q53848811 | Therapeutic implications of a combined diagnostic workup including endomyocardial biopsy in an all-comer population of patients with heart failure: a retrospective analysis. |
| Q28076640 | Three-Dimensional Endo-Cardiovascular Volume-Rendered Cine Computed Tomography of Isolated Left Ventricular Apical Hypoplasia: A Case Report and Literature Review |
Search more.